TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
PolyPeptide Laboratories (Sweden) AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
96,095
|
80,994
|
95,551 |
Financial expenses |
2,116
|
331
|
321 |
Earnings before taxes |
17,474
|
26,925
|
39,885 |
EBITDA |
23,322
|
25,035
|
40,959 |
Total assets |
179,465
|
136,323
|
140,395 |
Current assets |
119,431
|
80,454
|
96,218 |
Current liabilities |
37,599
|
28,287
|
33,120 |
Equity capital |
100,883
|
94,038
|
95,349 |
- share capital |
1,036
|
1,033
|
1,124 |
Employees (average) |
312
|
325
|
297 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
56.2%
|
69.0%
|
67.9% |
Turnover per employee |
308
|
249
|
322 |
Profit as a percentage of turnover |
18.2%
|
33.2%
|
41.7% |
Return on assets (ROA) |
10.9%
|
20.0%
|
28.6% |
Current ratio |
317.6%
|
284.4%
|
290.5% |
Return on equity (ROE) |
17.3%
|
28.6%
|
41.8% |
Change turnover |
14,865
|
-6,817
|
23,972 |
Change turnover % |
18%
|
-8%
|
33% |
Chg. No. of employees |
-13
|
28
|
31 |
Chg. No. of employees % |
-4%
|
9%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.